Centro Medico Issemym

Quick facts

Phase 3 pipeline

• Lower albumin dosage · Critical Care / Supportive Care
  Lower albumin dosage reduces the amount of human serum albumin administered to patients, potentially minimizing exposure-related adverse effects while maintaining therapeutic benefit.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Centro Medico Issemym portfolio CI brief
• Centro Medico Issemym pipeline updates RSS